glp-1 news today obesity drug updates today Chart: 1 in 8 Americans Now Use GLP-1 Drugs for Weight Loss Recent Trends in GLP-1 Use

J Hepatol 2023;79:888-97.PubMed 118

While semaglutide is generally well tolerated, it is most commonly associated with gastrointestinal symptoms such as nausea or diarrhea, especially during the early stages of treatment or when the dose is increased

The company didnt disclose the planned price of the generic, noting only that it will cost less than branded Victoza. The branded drug costs between $500 and $815 per package, depending on the dosage, before discounts or insurance, according to Novo Nordisk, which also sells a version of liraglutide approved for obesity, called Saxenda

ALL RIGHTS RESERVED

Quite similar results, although of lesser extent and for lesser outcomes, have been observed with GLP-1RA [29]

However, its mechanism of action is linked to reduced bone formation and reduced osteoclast surfaces